Glaucoma | Glaucoma CME Learning Center

Glaucoma
CME Learning Center

Conference Coverage

CME Clinical Update From the American Academy of Ophthalmology (AAO) 2008 Annual Meeting
Update in the diagnosis and management of patients with various ophthalmic issues from the American Academy of Ophthalmology (AAO) 2008 Annual Meeting.
Medscape Ophthalmology, February 2009
CME/CE Ocular Surface Disease and Antiglaucoma Pharmaceuticals
The potential association between glaucoma medications and ocular surface disease were explored at ARVO 2008.
Medscape Ophthalmology, May 2008
CME/CE Investigating the Biomechanical Properties of the Eye
Reports at ARVO 2008 focused on improving the understanding of biomechanical properties of the eye to better determine the mechanisms of glaucoma as well as optimize glaucoma screening.
Medscape Ophthalmology, May 2008
CME/CE Advances in Glaucoma Treatment
Advances in medical and surgical therapy for glaucoma were highlighted at ARVO 2008.
Medscape Ophthalmology, May 2008
CME/CE ARVO 2008: Glaucoma
Glaucoma highlights at ARVO 2008 included advances in medical and surgical therapy, a better understanding of ocular surface disease, and new research into the biomechanics of disease.
Medscape Ophthalmology, May 2008
CME/CE Investigating the Biomechanical Properties of the Eye
Reports at ARVO 2008 focused on improving the understanding of biomechanical properties of the eye to better determine the mechanisms of glaucoma as well as optimize glaucoma screening.
Medscape Ophthalmology, May 2008
CME/CE Advances in Glaucoma Treatment
Advances in medical and surgical therapy for glaucoma were highlighted at ARVO 2008.
Medscape Ophthalmology, May 2008
CME/CE Ocular Surface Disease and Antiglaucoma Pharmaceuticals
The potential association between glaucoma medications and ocular surface disease were explored at ARVO 2008.
Medscape Ophthalmology, May 2008

Features

Secondary Neuroprotective Effects of Hypotensive Drugs and Potential Mechanisms of Action CME Can topical therapy for primary open-angle glaucoma not only reduce intraocular pressure but protect retinal ganglion cells vital to vision as well? The current study evaluates this issue.
Expert Review of Ophthalmology, April 2012
FDA Approvals: First Preservative-Free Prostaglandin Eye Drops for Glaucoma CME/CE The FDA has approved tafluprost, the first preservative-free prostaglandin analogue ophthalmic solution, to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Medscape Education Clinical Briefs, February 2012
Erectile Dysfunction Linked With Prior Diagnosis of Glaucoma CME A study in Taiwan shows that men with erectile dysfunction have an almost 3-fold greater risk of having a previous diagnosis of open-angle glaucoma than men with normal erectile function.
Medscape Education Clinical Briefs, February 2012
Intraocular Pressure Elevation in Uveitis CME How should physicians approach patients with elevated intraocular pressure and uveitis? The current review provides answers.
Expert Review of Ophthalmology, February 2012
Cytomegalovirus-Associated Anterior Segment Infection CME Early diagnosis and treatment of CMV-associated anterior segment infection is essential to avoid visual loss, and therapy of glaucoma is an important adjunct to management.
Expert Review of Ophthalmology, October 2011
Lowering Intraocular Pressure in Glaucoma: Medical Therapy vs Surgical Therapy Drs. L. Jay Katz, Ronald Gross, and Brian Francis discuss the evolving medical and surgical approaches to lowering IOP in patients with glaucoma.
Medscape Education Ophthalmology, November 2010
The Relationship Between Visual Field Loss in Glaucoma and Quality of Life What factors reduce health-related quality of life among patients with glaucoma? The current study uses a large patient cohort to address this question.
Eye, November 2010
Frequency Doubling Technique Perimetry and Spectral Domain Optical Coherence Tomography in Patients With Early Glaucoma Can the combination of diagnostic testing for glaucoma provide superior results to single testing alone? The current study examines this question.
Eye, November 2010
Glaucoma and Ocular Surface Disease: Differentiating Between Disease and Treatment Side Effects Drs. Robert Fechtner and Clark Springs discuss how best to manage 2 challenging cases of patients with co-occurring glaucoma and ocular surface disease.
Medscape Education Ophthalmology, August 2010
Trabeculectomy With Mitomycin C vs ologen™ Implant in Open Angle Glaucoma In a prospective, randomized trial, complete success rate for trabeculectomy with ologen™ implant was lower than that for trabeculectomy with mitomycin C (MMC), but bleb morphology caused more problems in the MMC group.
Eye, August 2010
Pressure-Independent Approaches to the Treatment of Glaucoma Is neuroprotection a viable treatment option for glaucoma? Drs. Robert Weinreb, Jay Katz, and Theodore Krupin explore the possibilities.
Medscape Education Ophthalmology, June 2010
Early Treatment of Ocular Hypertension May Reduce Risk for Glaucoma A study shows that early treatment of ocular hypertension appears to lower the risk for the development of glaucoma, especially in individuals at highest risk.
Medscape Education Clinical Briefs, March 2010
Use of Glaucoma Medications Linked to Reduced Likelihood of Death Patients with glaucoma who took medication for the condition had a 74% reduced risk for death during a 4-year period vs those with no glaucoma medication use.
Medscape Education Clinical Briefs, February 2010
Neuroprotection and Glaucoma Dr. Theodore Krupin discusses the advances and setbacks in studies looking at the use of neuroprotection for glaucoma.
Medscape Education Ophthalmology, January 2010
Anterior Segment Imaging for Assessment of Glaucoma Traditional tools for the assessment of the angle and anterior segment may be invasive (involving the use of a contact lens) and provide inadequate visualization. OCT and UBM have advantages that may increase their use in the future.
Expert Review of Ophthalmology, January 2010
Improving Medication Adherence in Patients With Glaucoma Dr. Robert Noecker examines new research from the AAO 2009 to discuss improving adherence to medication in patients with glaucoma.
Medscape Education Ophthalmology, December 2009
Quality-of-Life Issues in Glaucoma and Glaucoma Therapy Drawing on findings presented at the WGC 2009, Dr. Ivan Goldberg explores the effect of both glaucoma and glaucoma treatment on quality of life.
Medscape Education Ophthalmology, August 2009
Initial Trabeculectomy With Mitomycin C in Eyes With Uveitic Glaucoma Although treatment of the causative disease and medical ocular hypotensive therapy are the first choices for control of intraocular pressure reduction in patients with uveitic glaucoma, surgical therapy often becomes necessary.
Eye, July 2009
Glaucoma and Ocular Surface Disease: An Expert Interview With Dr. Deepak Edward In this interview, Dr. Deepak Edward discusses the intersection of glaucoma with ocular surface disease.
Medscape Education Ophthalmology, May 2009
Progress Toward Personalized Medicine for Glaucoma Personalized medicine for glaucoma will become a reality through identification of disease and pharmacogenetic markers.
Expert Review of Ophthalmology, April 2009

Latest Clinical Briefs in Glaucoma

Unrecognized Eye Disorders Linked to Sleep Disorders CME
November 2008
Thyroid Disorders May Increase Risk for Glaucoma
October 2008
Treated Open-Angle Glaucoma Linked with CV-Related Death
March 2008
FDA Approvals: Combigan and Tasigna
November 2007
FDA Safety Changes: Betoptic S, Fragmin, Doxil
September 2007

About Glaucoma

Glaucoma -- a heterogeneous group of disorders marked by damage to the optic nerve -- is the second leading cause of blindness worldwide. Primary open-angle glaucoma, which is usually detected via elevated intraocular pressure (IOP), is the most common diagnosis, while angle-closure glaucoma can cause the most sudden and devastating vision loss. Early diagnosis is the key to successful management of glaucoma. Treatment strategies generally entail IOP-lowering drops, but may include trabeculectomy or other surgery as well as newer, neuroprotective approaches.

GlaucomaCME Learning Center

Conference Coverage

Features

Latest Clinical Briefs in Glaucoma

About Glaucoma

Glaucoma
CME Learning Center